Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Acq. announced
Director departure
Letter to company
Asset disposition
Appointed director
|
|
NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/15/2023 |
3
| Dais Craig (CFO) has filed a Form 3 on NAVIDEA BIOPHARMACEUTICALS, INC. |
| 07/17/2023 |
3
| Moss Dana J (Director) has filed a Form 3 on NAVIDEA BIOPHARMACEUTICALS, INC. |
| 06/09/2023 |
3
| Stefanelli Jill (Director) has filed a Form 3 on NAVIDEA BIOPHARMACEUTICALS, INC. |
| 10/25/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 11/12/2021 |
3
| FARB THOMAS F (Director) has filed a Form 3 on NAVIDEA BIOPHARMACEUTICALS, INC. |
| 10/19/2021 |
3
| Winkler Agnieszka (Director) has filed a Form 3 on NAVIDEA BIOPHARMACEUTICALS, INC. |
| 10/05/2021 |
3
| Mikhail Michel (Chief Regulatory Officer) has filed a Form 3 on NAVIDEA BIOPHARMACEUTICALS, INC. |
| 07/13/2021 |
3
| CAPPELLO ALEXANDER L (Director) has filed a Form 3 on NAVIDEA BIOPHARMACEUTICALS, INC. |
| 05/06/2021 |
3
| Bhalla Amit (Director) has filed a Form 3 on NAVIDEA BIOPHARMACEUTICALS, INC. |
| 12/30/2020 |
3
| Witter Malcolm G (Director) has filed a Form 3 on NAVIDEA BIOPHARMACEUTICALS, INC. |
| 11/06/2020 |
3
| Kaufman Joel H. (Chief Business Officer) has filed a Form 3 on NAVIDEA BIOPHARMACEUTICALS, INC. |
| 12/19/2018 |
3
| Rosol Michael Stanley (Chief Medical Officer) has filed a Form 3 on NAVIDEA BIOPHARMACEUTICALS, INC. |
| 12/12/2018 |
3
| Rouan Sarah Kathryn (Director) has filed a Form 3 on NAVIDEA BIOPHARMACEUTICALS, INC. |
| 12/11/2018 |
3
| Cutler Adam D. (Director) has filed a Form 3 on NAVIDEA BIOPHARMACEUTICALS, INC. |
| 09/24/2018 |
3
| Scott John K Jr. (10% Owner) has filed a Form 3 on NAVIDEA BIOPHARMACEUTICALS, INC. |
| 03/14/2018 |
3
| Bruck Claudine (Director) has filed a Form 3 on NAVIDEA BIOPHARMACEUTICALS, INC. |
| 05/11/2016 |
3
| RICE YEHUDA MICHAEL (Director) has filed a Form 3 on NAVIDEA BIOPHARMACEUTICALS, INC. |
| 04/27/2016 |
3
| Latkin Jed (Interim COO) has filed a Form 3 on NAVIDEA BIOPHARMACEUTICALS, INC. |
| 04/05/2016 |
3
| Greene Mark I (Director) has filed a Form 3 on NAVIDEA BIOPHARMACEUTICALS, INC. |
| 04/04/2016 |
3
| Fiorino Anthony S. (Director) has filed a Form 3 on NAVIDEA BIOPHARMACEUTICALS, INC. |
| 11/09/2012 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 11/02/2012 |
3
| Reininger Cornelia (SVP & Chief Medical Officer) has filed a Form 3 on NAVIDEA BIOPHARMACEUTICALS, INC. |
| 10/10/2012 |
3
| Regan William J. (SVP of lobal Regulatory Strate) has filed a Form 3 on NAVIDEA BIOPHARMACEUTICALS, INC. |
| 08/19/2011 |
3
| Tulip Thomas H. (EVP & Chief Business officer) has filed a Form 3 on NEOPROBE CORP |
| 04/26/2011 |
3
| JONES JESS (Director) has filed a Form 3 on NEOPROBE CORP |
| 04/26/2011 |
3
| DRAKE PETER F (Director) has filed a Form 3 on NEOPROBE CORP |
| 11/16/2010 |
3
| PYKETT MARK JEROME (EVP) has filed a Form 3 on NEOPROBE CORP |
| 07/19/2010 |
3
| Rowinsky Eric K (Director) has filed a Form 3 on NEOPROBE CORP |
| 07/19/2010 |
3
| FORD BRENDAN A (Director) has filed a Form 3 on NEOPROBE CORP |
|
|